CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ¹Ú¼ºÃ¶
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ±Þ¼º ¹× ¸¸¼ºÅëÁõ
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
68 (±¹³»)±âŸ Asystole during microvascular decompression in case of trigeminal neuralgia -A case report-
67 (±¹³»)KCI ÀÓ»êºÎ¿¡¼­ ¿ì¹ßÀû °æ¸·ÃµÀÚ¿Í Àü½Å¸¶ÃëÇÏ Á¦¿ÕÀý°³¼ú ÈÄ ¹ß°ßµÈ ³ú³»ÃâÇ÷ -Áõ·Ê º¸°í-
66 (±¹³»)KCI Comparison between monitored anesthesia care with remifentanil under ilioinguinal hypogastric nerve block and spinal anesthesia for herniorrhaphy
65 (±¹³»)±âŸ Àü½Å¸¶ÃëÀ¯µµ Áß ¹ß»ýÇÑ ½É¹æ¼¼µ¿°ú ȸº¹Áß ¹ß»ýÇÑ ¹ßÀÛ¼º »ó½É½Ç¼º ºó¸Æ
64 (±¹³»)KCIÈĺ¸ Á¦¿ÕÀý°³¼úÀ» À§ÇÑ Ã´Ãß ¸¶Ãë ½Ã 0.5 °íºñÁß bupivacaine¿¡ È¥ÇÕµÈfentanylÀÇ ¿ë·®¿¡ µû¸¥ ÀÓ»óÀû ºñ±³
63 (±¹³»)SCOPUS Comparison of clinical effects according to the dosage of sufentanil added to 0.5 hyperbaric bupivacaine for spinal anesthesia in patients undergoing cesarean section
62 (±¹¿Ü)SCI Incidence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection
61 (±¹³»)SCOPUS The optimal effect-site concentration of remifentanil to attenuate the pain caused by propofol.
60 (±¹¿Ü)SCIE Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis
59 (±¹³»)KCIÈĺ¸ ´Ù¹ß¼º °æÈ­Áõ »ê¸ð¿¡¼­ Á¦¿ÕÀý°³¼úÀ» À§ÇÑ Àü½Å¸¶Ãë -Áõ·Ê º¸°í-
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729